What is the official website of Sandoz Hrvatska ?

The official website of Sandoz Hrvatska is https://www.sandoz.hr/.

What is Sandoz Hrvatska's cybersecurity risk score?

Sandoz Hrvatska has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Hrvatska experienced?

According to Rankiteo, Sandoz Hrvatska currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Hrvatska been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Hrvatska has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Hrvatska have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Hrvatska is not certified under SOC 2 Type 1.

Does Sandoz Hrvatska have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Hrvatska does not hold a SOC 2 Type 2 certification.

Does Sandoz Hrvatska comply with GDPR ?

According to Rankiteo, Sandoz Hrvatska is not listed as GDPR compliant.

Does Sandoz Hrvatska have PCI DSS certification ?

According to Rankiteo, Sandoz Hrvatska does not currently maintain PCI DSS compliance.

Does Sandoz Hrvatska comply with HIPAA ?

According to Rankiteo, Sandoz Hrvatska is not compliant with HIPAA regulations.

Does Sandoz Hrvatska have ISO 27001 certification ?

According to Rankiteo,Sandoz Hrvatska is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Hrvatska operate in ?

Sandoz Hrvatska operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Hrvatska have ?

Sandoz Hrvatska employs approximately 30 people worldwide.

Does Sandoz Hrvatska own any subsidiaries ?

Sandoz Hrvatska presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Hrvatska have ?

Sandoz Hrvatska's official LinkedIn profile has approximately 3,890 followers.

What is the NAICS classification code for Sandoz Hrvatska ?

Sandoz Hrvatska is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Hrvatska have a Crunchbase profile ?

No, Sandoz Hrvatska does not have a profile on Crunchbase.

Does Sandoz Hrvatska have a LinkedIn profile ?

Yes, Sandoz Hrvatska maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-hrvatska.

How many cybersecurity incidents has Sandoz Hrvatska experienced ?

As of September 13, 2026, Rankiteo reports that Sandoz Hrvatska has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Hrvatska have ?

Sandoz Hrvatska has an estimated 5,760 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Hrvatska

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Sandoz Hrvatska Vendor Cyber Rating & Cyber Score

sandoz.hr

Add Your Compliance Badge

Sigurnost naših proizvoda, zdravlje i dobrobit pacijenata naši su glavni prioriteti.

Sandoz Hrvatska

Sandoz Hrvatska CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Hrvatska Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Hrvatska

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Hrvatska in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Hrvatska in 2026.

Incident Types Sandoz Hrvatska vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Hrvatska in 2026.

Incident History - Sandoz Hrvatska (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Hrvatska Subsidiaries

Sandoz Hrvatska

Pharmaceutical Manufacturing

Website: https://www.sandoz.hr/

Company Size: 51-200 employees

SandozPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz NederlandPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Loading…

Sandoz Hrvatska Similar Companies

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Loading…

NEWS

Sandoz Hrvatska CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-90647

SUMMARY

ASE/Kalkitech ASE2000 V2 Communication Test Set 2.35 through 2.37 on Windows contains an improper certificate validation vulnerability in the IEC 60870-5-104 TLS client (Task Mode). This allows a network-positioned attacker to bypass certificate validation via a certificate with multiple simultaneous faults, enabling a Man-in-the-Middle attack on protected communications.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.2

REFERENCES

https://www.ase-systems.com/wp-content/uploads/2026/07/CYB_2026_86278_Advisory_v1.0.pdf

CVE-2026-90487

SUMMARY

A vulnerability was found in Xuxueli xxl-job up to 3.4.2. Affected by this issue is some unknown functionality of the file xxl-job-admin/src/main/java/com/xxl/job/admin/business/controller/JobGroupController.java. The manipulation results in improper privilege management. The attack may be launched remotely. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-90486

SUMMARY

A vulnerability has been found in openstatusHQ openstatus up to f04c827112f30a11d571ebdad3892826034d6265. Affected by this vulnerability is an unknown functionality of the file apps/status-page/src/lib/proxy/resolve-custom-domain-rewrite.ts. The manipulation leads to server-side request forgery. The attack may be initiated remotely. This product uses a rolling release model to deliver continuous updates. As a result, specific version information for affected or updated releases is not available. The identifier of the patch is 86f370c9c20074c3c3fdec53a359874b8e670fd4. It is suggested to install a patch to address this issue. This issue got fixed with a silent patch.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-79300

SUMMARY

SEP sesam before 5.2.0.24 mishandles User Authorization with MFA. If AD authentication is configured and MFA is enforced, an attacker can create a second OTP access capability. SEP sesam and Active Directory handle username capitalization differently, which may allow multiple SEP sesam user accounts to be created for the same Active Directory (AD) account. Active Directory treats usernames as case-insensitive, while SEP sesam distinguishes between different letter casing. As a result, the same AD user can be represented by multiple SEP sesam user accounts that differ only in username capitalization. When Active Directory authentication is configured and multi-factor authentication (MFA) is enforced, this behavior may allow an additional OTP Authenticator to be registered for the same AD account, reducing the effectiveness of MFA protection.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 3.5)

cvss3

Base Score: 3.5

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:N/I:L/A:N

Impact Score

1.4

Exploitability

1.8

REFERENCES

https://wiki.sep.de/wiki/index.php/Release_Notes_5.2.0_Artemis#fixed

CVE-2026-90485

SUMMARY

A flaw has been found in IOBit Uninstaller 15.5.0.11. Affected by this issue is the function sub_11838 of the file IURegistryFilter.sys of the component IOCTL Dispatch Handler. This manipulation causes null pointer dereference. The attack requires local access. The exploit has been published and may be used. Identical IURegistryFilter.sys ships across multiple IObit families. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 5.5)

cvss2

Base Score: 4.6

Complexity: LOW

AV:L/AC:L/Au:S/C:N/I:N/A:C

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 5.4

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Sandoz Hrvatska Vendor Cyber Rating & Cyber Score

Sandoz Hrvatska A.I CyberSecurity Scoring

Sandoz Hrvatska CyberSecurity News & History

Sandoz Hrvatska Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sandoz Hrvatska

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sandoz Hrvatska vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sandoz Hrvatska (X = Date, Y = Severity)

Sandoz Hrvatska Subsidiaries

Sandoz Hrvatska

Sandoz Hrvatska Similar Companies

PT Kalbe Farma, Tbk

Teva Pharmaceuticals

Novartis

Lonza

Merck

Alkem Laboratories Ltd.

Sandoz

Takeda

Merck Group

Sandoz Hrvatska CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Sandoz Hrvatska CyberSecurity News & History

Sandoz Hrvatska Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Sandoz Hrvatska

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Sandoz Hrvatska vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Sandoz Hrvatska (X = Date, Y = Severity)

Sandoz Hrvatska Subsidiaries

Sandoz Hrvatska

Sandoz Hrvatska Similar Companies

PT Kalbe Farma, Tbk

Teva Pharmaceuticals

Novartis

Lonza

Merck

Alkem Laboratories Ltd.

Sandoz

Takeda

Merck Group

Sandoz Hrvatska CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo